The stock was sold at an average price of $64.18 per share, for a total transaction price of $1.54 million. Ms. Gulmi now owns 118,057 company shares, which are valued at approximately $7.58 million.
AmSurg has a one-year low of $40 and a one-year high of $65.03, according to the report.
More articles on transactions and valuation issues:
Surgery Partners prepares to file IPO
5 things to know about North Carolina’s CON reform bill
Study questions the efficacy of CON programs
